Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/12/2012 | US20120010230 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
01/12/2012 | US20120010218 Formulations |
01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
01/12/2012 | US20120010138 Novel uses of vegfxxxb |
01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
01/12/2012 | US20120010123 Methods of treating metabolic disorders and cardiovascular diseases |
01/12/2012 | US20120010107 Selection by compartmentalised screening |
01/12/2012 | US20120010099 Diagnostic markers of wound infection |
01/12/2012 | US20120010098 Selection by compartmentalised screening |
01/12/2012 | US20120010095 Methods for diagnosis and prognosis of pulmonary hypertension |
01/12/2012 | US20120010094 Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers |
01/12/2012 | US20120010092 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof |
01/12/2012 | US20120010090 Method of diagnosing breast cancer |
01/12/2012 | US20120009686 Method of measuring the concentration of a glycosaminoglycan anticoagulant |
01/12/2012 | US20120009667 Apparatus and method for analyzing fluid sample |
01/12/2012 | US20120009665 Methods of producing multi-layered microfluidic devices |
01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
01/12/2012 | US20120009619 Unitary cartridge for particle processing |
01/12/2012 | US20120009611 Biosensor and biosensor manufacturing method |
01/12/2012 | US20120009610 Endostatin as a marker of heart failure |
01/12/2012 | US20120009609 Devices and methods for detecting amniotic fluid in vaginal secretions |
01/12/2012 | US20120009608 Biomarker for the monitoring and prognosis of chronic myeloproliferative disorders |
01/12/2012 | US20120009607 Differentiating cardiac- and diabetes mellitus-based causes of kidney damage |
01/12/2012 | US20120009606 Peptide biomarkers predictive of renal function decline and kidney disease |
01/12/2012 | US20120009605 New assays for preimplantation factor and preimplantation factor peptides |
01/12/2012 | US20120009604 Use of grf1 protein for screening molecules |
01/12/2012 | US20120009602 Reagents and Methods for Assessment of Human Tumor Malignancy and for Targeting Malignant Tumor Cells |
01/12/2012 | US20120009601 Methods and compositions for reprogramming cells |
01/12/2012 | US20120009600 Method of diagnosing adolescent idiopathic scoliosis |
01/12/2012 | US20120009598 T2r, a novel family of taste receptors |
01/12/2012 | US20120009597 Biomarker for Barrett's Oesophagus |
01/12/2012 | US20120009596 Protein markers for detecting liver cancer and method for identifying the markers thereof |
01/12/2012 | US20120009595 Binding of aggregated forms of proteins |
01/12/2012 | US20120009594 Method for measuring beta-glucan, and beta-glucan-binding protein for use in the method |
01/12/2012 | US20120009593 Analysis method for the in vitro diagnosis of benign prostatic hyperplasia (bph) in dogs by assaying canine prostate specific esterase, and bph treatment follow up |
01/12/2012 | US20120009592 Enpp1 (pc-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications |
01/12/2012 | US20120009591 Method for detection of an enzyme-substrate reaction |
01/12/2012 | US20120009590 Device and non-toxic compositions and methods for permeabilization of drosophila embryos |
01/12/2012 | US20120009588 Live bioload detection using microparticles |
01/12/2012 | US20120009586 Method for detecting and qunantifying endogenous wheat dna sequence |
01/12/2012 | US20120009585 Method for detecting and qunantifying endogenous wheat dna sequence |
01/12/2012 | US20120009584 Method for detecting and qunantifying endogenous wheat dna sequence |
01/12/2012 | US20120009582 Diagnosis and treatment of breast cancer |
01/12/2012 | US20120009581 Gene Expression Profiling for Predicting the Survivability of Prostate Cancer Subjects |
01/12/2012 | US20120009579 Monocyte-derived nucleic acids and related compositions and methods |
01/12/2012 | US20120009576 Probe for Detection of Polymorphism in ABL Gene, and Use Thereof |
01/12/2012 | US20120009569 Microorganism concentration process and device |
01/12/2012 | US20120009309 Storage and packaging of bulk food items and method |
01/12/2012 | US20120009218 Attenuated Gram Negative Bacteria |
01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
01/12/2012 | US20120009209 Enrichment and purification of infectious prion proteins |
01/12/2012 | US20120009201 Renal cell carcinoma biomarkers |
01/12/2012 | US20120009197 Anti-Human Equilibrative Nucleoside Transporter 1 (hENT1) Antibodies and Methods of Use Thereof |
01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
01/12/2012 | US20120009174 Biomarkers for myocardial ischemia |
01/12/2012 | US20120009166 Isolated monocyte populations and related therapeutic applications |
01/12/2012 | US20120009143 Treating non-hematopoietic cancer with interleukin 6 |
01/12/2012 | US20120009125 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
01/12/2012 | US20120009095 Test strip with slot vent opening |
01/12/2012 | US20120008130 Correlation technique for analysis of clinical condition |
01/12/2012 | US20120006887 Sealing liquid for safety closures |
01/12/2012 | US20120006760 Microfluidic device for cell separation and uses thereof |
01/12/2012 | US20120006693 In Vitro Analyte Sensor and Methods of Use |
01/12/2012 | US20120006682 Nucleic acid concentration recovery cartridge, nucleic acid concentration recovery method, and fabrication process of cartridge |
01/12/2012 | US20120006130 Method for cullet qualtiy grading |
01/12/2012 | US20120006102 Sensor having a thin-film inhibition layer |
01/12/2012 | US20120006101 Method for determining the optimal treatment dosage for metals removal |
01/12/2012 | US20120006100 Method and/or system for determining blood glucose reference sample times |
01/12/2012 | DE202011108051U1 Teststreifen, insbesondere zum Nachweis von Glucose im Harn Test strips, in particular for detecting glucose in urine |
01/12/2012 | DE102010026723A1 Verfahren und Vorrichtung zum Bestimmen der Konzentration eines Blutbestandteils in einer mit Blut gefüllten Schlauchleitung Method and apparatus for determining the concentration of a blood constituent in a blood filled tubing |
01/12/2012 | DE102010026438A1 Lysimeter device for executing analysis in regions of e.g. ground, has lysimeter container whose lower side includes heat guide element, which stays in heat conducting contact with thermal conduction device |
01/12/2012 | DE102010026269A1 Verfahren zur schnellen serologischen Diagnostik eines Salmonellensubtyps Method for rapid serological diagnosis of Salmonella subtype |
01/12/2012 | DE102008007739B4 Referenzpräparat für eine Untersuchungsmethode unter Verwendung eines bildgebenden Erfassungs- und Auswertungsverfahrens und Verfahren zur Herstellung eines Referenzpräparats Reference preparation for an examination method using an imaging detection and evaluation process and procedures for the preparation of a reference preparation |
01/12/2012 | DE102007006736B4 In-vitro Testkit zur tierversuchsfreien Bestimmung des sensibilisierenden Potentials einer Substanz In vitro test kit for animal-free determination of the sensitizing potential of a substance |
01/12/2012 | DE102005053299B4 Hochtemperatur-Gassensorgehäuse High-temperature gas sensor housing |
01/12/2012 | CA2810170A1 Mu opioid receptor agonist analogs of the endomorphins |
01/12/2012 | CA2805331A1 Markers of vulnerability of the atherosclerosis plaque |
01/12/2012 | CA2804757A1 Apparatus and method for determining analyte content in a fluid |
01/12/2012 | CA2804686A1 Dual variable domain immunoglobulins and uses thereof |
01/12/2012 | CA2804486A1 Colormetric device for detecting, in an aqueous solution of interest, hydrolytic enzymatic activity with regard to at least one polymer of interest |
01/12/2012 | CA2804398A1 Novel method for characterizing and multi-dimensionally representing the folding process of proteins |
01/12/2012 | CA2804271A1 Prophylactic or therapeutic agent for diabetes |
01/12/2012 | CA2804269A1 Diagnosis and treatment of breast cancer |
01/12/2012 | CA2804218A1 Detection of target metabolites |
01/12/2012 | CA2804103A1 A planar support having an ultraflat surface and a device for detecting antigens comprising said planar support |
01/12/2012 | CA2803961A1 Therapeutic use of neural stem cells |
01/12/2012 | CA2803876A1 Metallation enhancements in tumor-imaging and pdt therapy |
01/12/2012 | CA2802893A1 Novel catalyst mixtures |
01/12/2012 | CA2802431A1 Methods of making a diagnostic composition and compositions therefrom |
01/12/2012 | CA2802305A1 Biomarker for hypertensive disorders of pregnancy |
01/12/2012 | CA2801110A1 Lung cancer biomarkers and uses thereof |
01/12/2012 | CA2800714A1 Fluorescent carbapenems |
01/12/2012 | CA2799223A1 Compositions and methods for stimulating magp-1 to improve the appearance of skin |
01/12/2012 | CA2743107A1 Particle interrogation devices and methods |
01/12/2012 | CA2742633A1 Particle interrogation devices and methods |
01/11/2012 | EP2405275A1 Stabilizing agent for management sample, management sample containing the stabilizing agent, and measurement kit comprising the management sample |
01/11/2012 | EP2405274A1 Monitoring anticoagulant therapy and identifying reversible direct factor Xa inhibitors |
01/11/2012 | EP2405273A1 Methods for detecting vitamin D metabolites by mass spectrometry |